- Investing Ideas
- /
- Chinese Healthcare Spotless Management
Chinese Healthcare Spotless Management
Results
2
0 new
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
2 companies
Shenzhen New Industries Biomedical Engineering
Market Cap: CN¥41.8b
Engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally.
300832
CN¥52.74
7D
-8.3%
1Y
-19.9%
Jafron BiomedicalLtd
Market Cap: CN¥18.8b
Engages in the research, development, production, and sales of blood purification products for hemadsorption field in worldwide.
300529
CN¥24.37
7D
-7.6%
1Y
6.5%